Acute Leukemia — Trials

Acute Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

4,655 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,259
Recruiting: 759
Ph III recruiting: 70
Growth YoY: −1.5%
Industry share: 16%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 36.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (720)

clinicaltrialsPublishedShowing 201–250 of 584 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07575971	Exploratory Study of CD22/CD19 Dual-Target CAR-T Cell Therapy as Consolidation Treatment After First Remission in High-Risk B-Cell Acute Lymphoblastic Leukemia	recruiting	Phase 1 / Phase 2	30	Liping DouOTHER	1	Jun 25, 2026	clinicaltrials
NCT02553460	Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I	active not recruiting	Phase 1 / Phase 2	50	St. Jude Children's Research HospitalOTHER	2	Jun 24, 2026	clinicaltrials